Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Liothyronine (T3) | Oxandrolone (Anavar) | |
|---|---|---|
| Category | Hormones | Hormones |
| Standard Dose | — | Research indicates 5-20 mg/day orally for therapeutic/recovery applications. Clinical burn protocols use 0.1 mg/kg twice daily. |
| Timing | — | Split into 2 doses (morning and evening) due to 9-hour half-life. Take with food to reduce GI discomfort. |
| Cycle Duration | — | Typical therapeutic cycles: 6-12 weeks. Clinical burn protocols have extended to 1 year+ with liver monitoring. Limit cycle length to minimize hepatic stress. |
| Evidence Level | Strong | strong_human |
Synthetic triiodothyronine that directly raises active thyroid hormone signaling.
Oxandrolone is a synthetic 17-alpha-alkylated dihydrotestosterone (DHT) derivative with a modified A-ring (replacement of C2 with an oxygen atom) that confers high anabolic-to-androgenic ratio (~10:1). It enhances protein synthesis by activating the androgen receptor while strongly binding sex hormone-binding globulin (SHBG), increasing free testosterone fraction. Oxandrolone directly stimulates phosphocreatine synthesis in skeletal muscle and has demonstrated anti-catabolic effects through cortisol receptor antagonism. In burn patients, it reverses catabolism by restoring the IGF-1/IGFBP-3 axis.
Research indicates 5-20 mg/day orally for therapeutic/recovery applications. Clinical burn protocols use 0.1 mg/kg twice daily.
Split into 2 doses (morning and evening) due to 9-hour half-life. Take with food to reduce GI discomfort.
Typical therapeutic cycles: 6-12 weeks. Clinical burn protocols have extended to 1 year+ with liver monitoring. Limit cycle length to minimize hepatic stress.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →